Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Marsh

Showing results (11-20 of 153) with videos related to

Pageof 16
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1988
A flexible peptide spacer increases the efficacy of holoricin anti-T cell immunotoxinsJ W Marsh, D M Neville
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1990
Development of a diphtheria toxin mutant conjugate directed against antigen-specific B cells expressing high affinity surface IgJ W Marsh, D M Klinman
Annals of the ICRP|October 24, 2012
Effective dose from inhaled radon and its progenyJ D Harrison, J W Marsh
Biochemistry|July 29, 1986
Kinetic comparison of ricin immunotoxins: biricin conjugate has potentiated cytotoxicityJ W Marsh, D M Neville
Journal of Virology|September 1, 1996
Human immunodeficiency virus type 1 Nef associates with a member of the p21-activated kinase familyM F Nunn, J W Marsh
Journal of Virology|August 1, 1994
Human immunodeficiency virus type 1 Nef-induced down-modulation of CD4 is due to rapid internalization and degradation of surface CD4S S Rhee, J W Marsh
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1994
HIV-1 Nef activity in murine T cells. CD4 modulation and positive enhancementS S Rhee, J W Marsh
The Journal of Biological Chemistry|March 4, 1994
HIV-1 Nef inhibits a common activation pathway in NIH-3T3 cellsS K De, J W Marsh
Cancer Treatment and Research|January 1, 1988
Methods for quantifying immunotoxin efficacyD M Neville, J W Marsh
Annals of the New York Academy of Sciences|January 1, 1987
Development of an immunotoxin with in vivo efficacy for murine systemsJ W Marsh, D M Neville
Pageof 16

Showing results (11-20 of 153) with videos related to

Sort By:
Pageof 16
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1988
A flexible peptide spacer increases the efficacy of holoricin anti-T cell immunotoxinsJ W Marsh, D M Neville
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1990
Development of a diphtheria toxin mutant conjugate directed against antigen-specific B cells expressing high affinity surface IgJ W Marsh, D M Klinman
Annals of the ICRP|October 24, 2012
Effective dose from inhaled radon and its progenyJ D Harrison, J W Marsh
Biochemistry|July 29, 1986
Kinetic comparison of ricin immunotoxins: biricin conjugate has potentiated cytotoxicityJ W Marsh, D M Neville
Journal of Virology|September 1, 1996
Human immunodeficiency virus type 1 Nef associates with a member of the p21-activated kinase familyM F Nunn, J W Marsh
Journal of Virology|August 1, 1994
Human immunodeficiency virus type 1 Nef-induced down-modulation of CD4 is due to rapid internalization and degradation of surface CD4S S Rhee, J W Marsh
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1994
HIV-1 Nef activity in murine T cells. CD4 modulation and positive enhancementS S Rhee, J W Marsh
The Journal of Biological Chemistry|March 4, 1994
HIV-1 Nef inhibits a common activation pathway in NIH-3T3 cellsS K De, J W Marsh
Cancer Treatment and Research|January 1, 1988
Methods for quantifying immunotoxin efficacyD M Neville, J W Marsh
Annals of the New York Academy of Sciences|January 1, 1987
Development of an immunotoxin with in vivo efficacy for murine systemsJ W Marsh, D M Neville
Pageof 16